Announced Wed, 1 Oct · 20:46 IST

AGM Voting Results Report

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Vaxfab Enterprises held its Annual General Meeting on September 30, 2025, and all 5 resolutions were passed with 100% votes in favor and zero votes against. The resolutions included routine items (adoption of FY25 audited financial statements, reappointment of a director, and ratification of secretarial auditors) as well as two special resolutions: an increase in the company's authorised share capital and the issuance of fully convertible warrants on a preferential basis. Out of 3,559 shareholders on record date, only 20 shareholders cast votes, representing about 23.77% of outstanding shares (2,058,441 shares). Notably, the promoter and promoter group did not participate in voting, and no institutional shareholders voted, meaning all votes came from the public non-institutional category. The meeting was conducted both physically and via remote e-voting through NSDL, and concluded within 20 minutes.

Likely market impact

The passing of the special resolutions means the company is now authorized to raise its share capital and issue convertible warrants to select investors on a preferential basis, which could lead to equity dilution for existing shareholders. However, with only ~24% shareholder participation and zero promoter votes, the results reflect limited engagement from the shareholder base, though all proposals were approved unanimously by those who voted.